Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study

INTRODUCTION: Delayed-release dimethyl fumarate (DMF, also known as gastro-resistant DMF) is indicated for the treatment of patients with relapsing multiple sclerosis. Gastrointestinal (GI) adverse events (AEs) occur with DMF therapy. METHODS: We used a Delphi process to reach consensus among North...

Descripción completa

Detalles Bibliográficos
Autores principales: Theodore Phillips, J., Erwin, April A., Agrella, Stephanie, Kremenchutzky, Marcelo, Kramer, John F., Darkes, Malcolm J. M., Kendter, Jonathan, Abourjaily, Heather, Rana, Jitesh, Fox, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685868/
https://www.ncbi.nlm.nih.gov/pubmed/26525536
http://dx.doi.org/10.1007/s40120-015-0037-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685868/
https://www.ncbi.nlm.nih.gov/pubmed/26525536
http://dx.doi.org/10.1007/s40120-015-0037-x

Ejemplares similares